TRAVERE THERAPEUTICS INC (TVTX)
US89422G1076 - Common Stock
| TTM (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -161.13M | -111.40M | -278.48M | -180.09M | -169.43M | |||
| Depreciation Amortization | 38.86M | 38.53M | 33.08M | 26.62M | 24.58M | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | -6.35M | -25.48M | 900.00K | 79.98M | -25.19M | |||
| Interest Paid | N/A | 8.84M | 10.16M | 7.33M | 6.90M | |||
| Taxes Paid | N/A | 578.00K | 1.00M | -16.42M | -3.37M | |||
| Other non cash items | -189.29M | -181.68M | 58.21M | 58.70M | 127.30M | |||
| OPERATING CASH FLOW | -317.91M | -280.02M | -186.29M | -14.79M | -42.74M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -20.75M | -42.26M | -28.56M | -24.15M | -24.57M | |||
| Other Investing Activity | 218.47M | 98.03M | -4.00M | -113.47M | -36.76M | |||
| INVESTING CASH FLOW | 197.71M | 55.78M | -32.55M | -137.62M | -61.33M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 0.00 | 0.00 | 104.93M | N/A | 0.00 | |||
| Stock Issued/Repurchased | 938.00K | 219.07M | 24.13M | 237.78M | 135.42M | |||
| Other Financing Activity | 289.00K | -316.00K | -11.48M | -6.09M | -7.70M | |||
| FINANCING CASH FLOW | 1.23M | 218.75M | 117.57M | 231.68M | 127.71M | |||
| Exchange Rate Effect | 838.00K | 1.98M | -2.79M | 1.71M | -1.31M | |||
| CHANGE IN CASH | -118.13M | -3.51M | -104.06M | 80.98M | 22.33M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -317.91M | -280.02M | -186.29M | -14.79M | -42.74M | |||
| Capital Expenditure | -20.75M | -42.26M | -28.56M | -24.15M | -24.57M | |||
| FREE CASH FLOW | -338.66M | -322.28M | -214.85M | -38.94M | -67.31M | |||
All data in USD